Quick Answer
ABEONA THERAPEUTICS INC. reported Revenue (ASC 606) of $5.82 million for fiscal year 2025.
ABEONA THERAPEUTICS INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $5.82M | +66.3% |
| 2023 | $3.50M | +147.5% |
| 2022 | $1.41M | -52.9% |
| 2021 | $3.00M | -70.0% |
| 2020 | $10.00M | +233.6% |
| 2018 | $3.00M | +258.2% |
| 2017 | $837.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $400.0K | — | -88.6% |
| June 30, 2023 | $3.50M | +250.0% | +250.0% |
| June 30, 2022 | $1.00M | — | +189.0% |
| March 31, 2022 | $346.0K | — | -95.1% |
| September 30, 2020 | $7.00M | — | +309.6% |
| September 30, 2018 | $1.71M | — | — |
- ABEONA THERAPEUTICS INC. showed an increase of +66.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, ABEONA THERAPEUTICS INC.’s revenue (asc 606) has grown by 595.3% (from $837.0 thousand to $5.82 million).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: